About MED-POLONIA Sp.z o.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
8
Janssen Research & Development, LLC
4
Boehringer Ingelheim
3
Clovis Oncology, Inc.
3
MacroGenics
3
BeiGene
2
Celgene
2
Daiichi Sankyo, Inc.
2
Emalex Biosciences Inc.
2
Gilead Sciences
2
Incyte Corporation
2
Clinical Trials at MED-POLONIA Sp.z o.o.
During the past decade, MED-POLONIA Sp.z o.o. conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 15 clinical trials were completed, i.e. on
average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 10 clinical trials were completed. i.e. 62.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer
2012-09-01
2017-07-01
Unknown status
700
A Study of Vemurafenib Adjuvant Therapy in Participants With Surgically Resected Cutaneous BRAF-Mutant Melanoma
2012-09-24
2018-07-13
Completed
498
An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)
2013-07-17
2023-12-31
Active, not recruiting
481
A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing Therapy
2014-03-11
2019-01-09
Completed
1,225
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer
2014-06-01
2016-05-01
Terminated
265
Combination Therapy With NC-6004 and Gemcitabine in Advanced Solid Tumors or Non-Small Cell Lung, Biliary and Bladder Cancer
2014-05-01
2019-05-06
Completed
209
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
2015-07-20
2022-03-08
Completed
572
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "MED-POLONIA Sp.z o.o." #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Janssen Research & Development, LLC" with 4 trials
sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Clovis Oncology, Inc." with 3 trials sponsored and "MacroGenics"
with 3 trials sponsored. Other sponsors include 32 different institutions and
companies that sponsored additional 34 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "MED-POLONIA Sp.z o.o."
#1 collaborator was "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "BioNTech SE" with 1 trials as a collaborator and "Breast International Group" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at MED-POLONIA Sp.z o.o.
According to Clinical.Site data, the most researched conditions in "MED-POLONIA Sp.z o.o." are
"Carcinoma, Non-Small-Cell Lung" (6 trials), "Neoplasms" (6 trials), "Non-small Cell Lung Cancer" (4 trials), "Melanoma" (3 trials) and "Non Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "MED-POLONIA Sp.z o.o." in a lesser frequency.
Clinical Trials Intervention Types at MED-POLONIA Sp.z o.o.
Most popular intervention types in "MED-POLONIA Sp.z o.o." are "Drug" (51 trials), "Biological" (9 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (13 trials), "Carboplatin" (7 trials), "Pemetrexed" (5 trials), "Cisplatin" (4 trials) and "Docetaxel" (4 trials). Other intervention names were less common.
Clinical Trials Genders at MED-POLONIA Sp.z o.o.
The vast majority of trials in "MED-POLONIA Sp.z o.o." are
58 trials for "All" genders.
Clinical Trials Status at MED-POLONIA Sp.z o.o.
Currently, there are NaN active trials in "MED-POLONIA Sp.z o.o.".
undefined are not yet recruiting,
13 are recruiting,
16 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 22 completed trials in MED-POLONIA Sp.z o.o.,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in MED-POLONIA Sp.z o.o., 12 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 31 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".